• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎患者群体中总胆固醇与高密度脂蛋白比值和非酒精性脂肪性肝病的关系

Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B.

作者信息

Zhou Yu-Ge, Tian Ning, Xie Wei-Ning

机构信息

Affiliated Guangdong Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Foshan 528200, Guangdong Province, China.

Preventive Healthcare Center, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan 528200, Guangdong Province, China.

出版信息

World J Hepatol. 2022 Apr 27;14(4):791-801. doi: 10.4254/wjh.v14.i4.791.

DOI:10.4254/wjh.v14.i4.791
PMID:35646261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9099113/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is characterized by hypertriglyceridemia, increased low-density lipoprotein cholesterol levels, and reduced high-density lipoprotein cholesterol (HDL-C) particles. Previous studies have shown that the total cholesterol to high-density lipoprotein cholesterol ratio (TC/HDL-C) was superior to other lipid metabolism biomarkers for predicting NAFLD risk and could be a new indicator of NAFLD. However, the association between TC/HDL-C and NAFLD in patients with hepatitis B virus (HBV) has not yet been determined.

AIM

To investigate the association between TC/HDL-C and NAFLD in a population with chronic hepatitis B (CHB).

METHODS

In this study, 183 HBV-infected patients were enrolled. All participants underwent blood chemistry examinations and abdominal ultrasound. Univariate and multivariate logistic regression models, curve fitting analysis, and threshold calculation were used to assess the relationship between TC/HDL-C and NAFLD.

RESULTS

The overall prevalence of NAFLD was 17.49% ( = 32) in the 183 CHB participants. The TC/HDL-C of non-NAFLD and NAFLD patients were 3.83 ± 0.75 and 4.44 ± 0.77, respectively ( < 0.01). Logistic regression analysis showed that TC/HDL-C was not associated with NAFLD after adjusting for other pertinent clinical variables. However, at an optimal cutoff point of 4.9, a non-linear correlation between TC/HDL-C and NAFLD was detected. The effect size of the left and right sides of the inflection point were 5.4 (95% confidence interval: 2.3-12.6, < 0.01) and 0.5 (95% confidence interval: 0.1-2.2, = 0.39), respectively. On the left side of the inflection point, TC/HDL-C was positively associated with NAFLD. However, no significant association was observed on the right side of the inflection point.

CONCLUSION

This study demonstrated a non-linear correlation between TC/HDL-C and NAFLD in a population with CHB. TC/HDL-C was positively associated with NAFLD when TC/HDL-C was less than 4.9 but not when TC/HDL-C was more than 4.9.

摘要

背景

非酒精性脂肪性肝病(NAFLD)的特征为高甘油三酯血症、低密度脂蛋白胆固醇水平升高以及高密度脂蛋白胆固醇(HDL-C)颗粒减少。既往研究表明,总胆固醇与高密度脂蛋白胆固醇比值(TC/HDL-C)在预测NAFLD风险方面优于其他脂质代谢生物标志物,可能是NAFLD的一项新指标。然而,TC/HDL-C与乙型肝炎病毒(HBV)感染患者的NAFLD之间的关联尚未确定。

目的

探讨慢性乙型肝炎(CHB)人群中TC/HDL-C与NAFLD之间的关联。

方法

本研究纳入了183例HBV感染患者。所有参与者均接受了血液生化检查和腹部超声检查。采用单因素和多因素逻辑回归模型、曲线拟合分析及阈值计算来评估TC/HDL-C与NAFLD之间的关系。

结果

183例CHB参与者中NAFLD的总体患病率为17.49%(n = 32)。非NAFLD和NAFLD患者的TC/HDL-C分别为3.83±0.75和4.44±0.77(P < 0.01)。逻辑回归分析显示,在调整其他相关临床变量后,TC/HDL-C与NAFLD无关。然而,在最佳截断点为4.9时,检测到TC/HDL-C与NAFLD之间存在非线性相关性。拐点左侧和右侧的效应大小分别为5.4(95%置信区间:2.3 - 12.6,P < 0.01)和0.5(95%置信区间:0.1 - 2.2,P = 0.39)。在拐点左侧,TC/HDL-C与NAFLD呈正相关。然而,在拐点右侧未观察到显著关联。

结论

本研究证明CHB人群中TC/HDL-C与NAFLD之间存在非线性相关性。当TC/HDL-C小于4.9时,TC/HDL-C与NAFLD呈正相关,而当TC/HDL-C大于4.9时则无此关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/9099113/0fcfb79d2fa2/WJH-14-791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/9099113/60a6b793edbe/WJH-14-791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/9099113/0fcfb79d2fa2/WJH-14-791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/9099113/60a6b793edbe/WJH-14-791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/9099113/0fcfb79d2fa2/WJH-14-791-g002.jpg

相似文献

1
Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B.慢性乙型肝炎患者群体中总胆固醇与高密度脂蛋白比值和非酒精性脂肪性肝病的关系
World J Hepatol. 2022 Apr 27;14(4):791-801. doi: 10.4254/wjh.v14.i4.791.
2
Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals.丙氨酸氨基转移酶与高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病的关系:一项在中国瘦人群体中的回顾性队列研究。
Sci Rep. 2024 Mar 13;14(1):6056. doi: 10.1038/s41598-024-56555-8.
3
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.总胆固醇与高密度脂蛋白胆固醇比值是预测非酒精性脂肪肝的一个重要指标:金昌队列研究。
Lipids Health Dis. 2019 Feb 11;18(1):47. doi: 10.1186/s12944-019-0984-9.
4
Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.脂代谢、体重指数与普通人群非酒精性脂肪性肝病风险的关系:基于中介分析的证据。
J Transl Med. 2023 Mar 13;21(1):192. doi: 10.1186/s12967-023-04047-0.
5
Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.传统和非传统脂质指标在日本人群中非酒精性脂肪肝诊断中的应用。
Lipids Health Dis. 2022 Oct 7;21(1):95. doi: 10.1186/s12944-022-01712-z.
6
Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: A secondary prospective cohort study in non-obese Chinese adults.γ-谷氨酰转移酶与高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病呈非线性关联:一项针对非肥胖中国成年人的二次前瞻性队列研究。
Front Med (Lausanne). 2022 Nov 17;9:995749. doi: 10.3389/fmed.2022.995749. eCollection 2022.
7
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis.乙型肝炎病毒感染合并非酒精性脂肪性肝病:相互作用与预后
Heliyon. 2023 Jan 20;9(1):e13113. doi: 10.1016/j.heliyon.2023.e13113. eCollection 2023 Jan.
8
Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.高血清尿酸与高密度脂蛋白胆固醇比值与血脂正常的非肥胖中国人群中非酒精性脂肪性肝病的发病有关。
BMC Gastroenterol. 2022 Apr 21;22(1):196. doi: 10.1186/s12876-022-02263-4.
9
Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease.残余胆固醇与非酒精性脂肪性肝病呈非线性关联。
Diabetes Res Clin Pract. 2023 Jul;201:110733. doi: 10.1016/j.diabres.2023.110733. Epub 2023 May 26.
10
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.非酒精性脂肪性肝病的严重程度与总胆固醇、甘油三酯与高密度脂蛋白胆固醇的比值相关。
J Clin Lipidol. 2016 Mar-Apr;10(2):420-5.e1. doi: 10.1016/j.jacl.2015.12.026. Epub 2016 Jan 7.

引用本文的文献

1
The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients.甘油三酯/高密度脂蛋白比值作为非酒精性脂肪性肝病早期阶段的无创标志物:一项对2588例患者的回顾性横断面研究。
Diagnostics (Basel). 2025 Aug 14;15(16):2045. doi: 10.3390/diagnostics15162045.
2
Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch.替诺福韦氨苯甲酰胺治疗慢性乙型肝炎:从富马酸替诺福韦二吡呋酯转换为替诺福韦氨苯甲酰胺后的血脂变化及144周安全性
World J Gastroenterol. 2025 Jul 14;31(26):109285. doi: 10.3748/wjg.v31.i26.109285.
3

本文引用的文献

1
LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study.LDL/HDL 胆固醇比值与中国非肥胖血脂正常人群新发非酒精性脂肪性肝病相关:一项为期 5 年的纵向队列研究。
Lipids Health Dis. 2021 Mar 25;20(1):28. doi: 10.1186/s12944-021-01457-1.
2
A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study.用于评估中国人群非酒精性脂肪性肝病概率的列线图:一项回顾性队列研究。
Medicine (Baltimore). 2020 Nov 25;99(48):e23049. doi: 10.1097/MD.0000000000023049.
3
Dysregulated lipid metabolism links NAFLD to cardiovascular disease.
Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis.
乙型肝炎患者中非酒精性脂肪性肝病的患病率:一项荟萃分析。
World J Clin Cases. 2024 Sep 6;12(25):5749-5760. doi: 10.12998/wjcc.v12.i25.5749.
4
Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study.非酒精性脂肪性肝病在慢性乙型肝炎非活动期患者中的患病率及其对纤维化风险的影响:一项横断面研究的见解
J Clin Med. 2024 Aug 12;13(16):4738. doi: 10.3390/jcm13164738.
5
Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study.红曲米治疗高脂血症患者肝硬化的真实世界风险与结局:一项回顾性队列研究
J Multidiscip Healthc. 2024 Jul 30;17:3727-3738. doi: 10.2147/JMDH.S466696. eCollection 2024.
脂质代谢失调将非酒精性脂肪性肝病与心血管疾病联系起来。
Mol Metab. 2020 Dec;42:101092. doi: 10.1016/j.molmet.2020.101092. Epub 2020 Oct 1.
4
Epidemiological Features of NAFLD From 1999 to 2018 in China.中国 1999 年至 2018 年非酒精性脂肪性肝病的流行病学特征。
Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150.
5
Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?慢性乙型肝炎与非酒精性脂肪性肝病:共谋者还是竞争者?
Liver Int. 2020 Mar;40(3):496-508. doi: 10.1111/liv.14369. Epub 2020 Jan 13.
6
A critical appraisal of the use of ultrasound in hepatic steatosis.超声在肝脂肪变性中的应用评价。
Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):667-681. doi: 10.1080/17474124.2019.1621164. Epub 2019 May 29.
7
Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.1997年至2016年中国肝癌的疾病负担:一项基于全球疾病负担的观察性研究
BMJ Open. 2019 Apr 23;9(4):e025613. doi: 10.1136/bmjopen-2018-025613.
8
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.总胆固醇与高密度脂蛋白胆固醇比值是预测非酒精性脂肪肝的一个重要指标:金昌队列研究。
Lipids Health Dis. 2019 Feb 11;18(1):47. doi: 10.1186/s12944-019-0984-9.
9
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
10
Chronic hepatitis B virus infection.慢性乙型肝炎病毒感染。
Lancet. 2018 Nov 24;392(10161):2313-2324. doi: 10.1016/S0140-6736(18)31865-8.